Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/24/16
End: 11/01/18
Due: 11/01/19
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 10/31/07
Due: 10/31/08
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 10/31/05
Due: 10/31/06
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder | NCT02623504 | Validus Pharmaceuticals | user2@example.com | None | 2016-10-24 | 2018-11-01 | 2019-11-01 | - | - | 2025-07-14 |
| The Young Adult and Pediatric Bipolar Study | NCT00350857 | Validus Pharmaceuticals | user2@example.com | None | 2006-07-31 | 2007-10-31 | 2008-10-31 | - | - | 2025-07-14 |
| Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder | NCT00150605 | Validus Pharmaceuticals | user2@example.com | None | 2005-02-28 | 2005-10-31 | 2006-10-31 | - | - | 2025-07-14 |
| Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder | NCT00150553 | Validus Pharmaceuticals | user2@example.com | None | 2005-01-31 | 2005-10-31 | 2006-10-31 | - | - | 2025-07-14 |